HPLC-MS/MS Analysis for Sphingosine 1-Phosphate after the Dephosphorylation by Hydrogen Fluoride
-
Published:2024-01-18
Issue:1
Volume:11
Page:34
-
ISSN:2297-8739
-
Container-title:Separations
-
language:en
-
Short-container-title:Separations
Author:
Kim Hee-Jung1, Jung Seo-Hyeon1, Gulyamov Shokhid1ORCID, Lee Hyun-Gy1, Boyjigitov Oybek1, Lee Yong-Moon1ORCID
Affiliation:
1. College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea
Abstract
Sphingosine 1-phosphate (S1P) is a signaling lipid molecule involved in various cellular processes. It is important to develop a quantitative method for S1P to determine endogenous levels and to investigate its functions. As S1P is a tiny lipid component of most biological samples, highly sensitive analysis by LC-MS/MS is required. The main challenge in S1P analysis by chromatography is peak-broadening due to the presence of a polar phosphate and the fact that S1P is indeed a zwitterion itself. In this study, we used hydrogen fluoride (HF) to efficiently remove a phosphate and then analyzed the surrogate, sphingosine, as a sharp peak by LC-ESI-MS/MS. We optimized the dephosphorylation reaction in terms of temperature and reaction time. Multiple reaction monitoring (MRM) for a dephosphorylated form of S1P and C17-S1P as an internal standard at m/z transition 300.4 > 282.4 (quantification ion), 300.4 > 262.4 (qualification ion), 286.3 > 268.2 (internal standard) was conducted. This method was validated by essential parameters such as specificity, linearity, range, LOQ, LOD, accuracy, precision, and repeatability. To confirm this new method, we quantified S1P levels in various serum products (100.0~284.4 nM). In the sample pretreatment conditions for extracting S1P, the concern about potential sphingosine contamination in serum was negligible. The dephosphorylation efficiency by this method was about two-fold higher than that of alkaline phosphatase (APase). To apply the method in vivo, we analyzed S1P in plasma and kidney tissues obtained from a chronic kidney disease (CKD) mouse model. S1P levels were increased only in CKD kidney tissue but not in plasma. In conclusion, by applying the dephosphorylation step with HF, we established a new, sensitive LC-MS/MS quantitative method for S1P that can be applied to biological samples.
Funder
the academic research program of Chungbuk National University
Subject
Filtration and Separation,Analytical Chemistry
Reference27 articles.
1. Nguyen, T.Q., Vu, T.M., Tukijan, F., Muralidharan, S., Foo, J.C., Li Chin, J.F., Hasan, Z., Torta, F., and Nguyen, L.N. (2021). Erythrocytes efficiently utilize exogenous sphingosines for S1P synthesis and export via Mfsd2b. J. Biol. Chem., 296. 2. S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: A narrative review;Constantinescu;Ther. Adv. Neurol. Disord.,2022 3. Novel methods for the quantification of (2E)-hexadecenal by liquid chromatography with detection by either ESI QTOF tandem mass spectrometry or fluorescence measurement;Luth;Anal. Chim. Acta,2012 4. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS);Bielawski;Adv. Exp. Med. Biol.,2010 5. Oizumi, H., Sugimura, Y., Totsune, T., Kawasaki, I., Ohshiro, S., Baba, T., Kimpara, T., Sakuma, H., Hasegawa, T., and Kawahata, I. (2022). Plasma sphingolipid abnormalities in neurodegenerative diseases. PLoS ONE, 17.
|
|